Document Detail


Sustained improvement with iloprost in a COPD patient with severe pulmonary hypertension.
MedLine Citation:
PMID:  19201716     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pulmonary hypertension is an important complication of COPD. A small subset of patients with COPD have severe pulmonary hypertension (PH) that is out of proportion to the mild increase in pulmonary arterial pressure observed commonly. Severe PH associated with COPD is associated with increased morbidity and mortality. Treatment options in this group of patients are limited with no conclusive evidence of benefit when drugs approved for treatment of pulmonary arterial hypertension are used. We describe a patient with severe PH associated with COPD who improved clinically and hemodynamically when treated with inhaled iloprost. The improvement was sustained for 2 years. Severe PH in patients with COPD needs to be recognized and novel treatment approaches considered.
Authors:
Matthew J Hegewald; C Gregory Elliott
Related Documents :
8989056 - Membrane diffusion and capillary blood volume in chronic thromboembolic pulmonary hyper...
10612386 - Pulmonary artery stenosis 5 years after single lung transplantation in primary pulmonar...
17892236 - Pulmonary hypertension: pathogenesis and management.
18091026 - Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension.
2388446 - Simultaneous coronary and abdominal aortic surgery--a report of two cases.
10348546 - Retrograde embolization during saphenous vein graft angioplasty.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Chest     Volume:  135     ISSN:  1931-3543     ISO Abbreviation:  Chest     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-02-09     Completed Date:  2009-04-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  536-7     Citation Subset:  AIM; IM    
Affiliation:
Division of Pulmonary and Critical Care Medicine Intermountain Medical Center, University of Utah School of Medicine, Salt Lake City, UT 84157-7000, USA. matt.hegewald@imail.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Aged
Blood Gas Analysis
Dose-Response Relationship, Drug
Drug Administration Schedule
Echocardiography, Transesophageal
Follow-Up Studies
Humans
Hypertension, Pulmonary / drug therapy*,  etiology,  ultrasonography
Iloprost / administration & dosage*
Male
Maximum Tolerated Dose
Pulmonary Disease, Chronic Obstructive / complications*,  diagnosis
Respiratory Function Tests
Risk Assessment
Severity of Illness Index
Treatment Outcome
Vasodilator Agents / administration & dosage*
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 78919-13-8/Iloprost

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Echocardiography performed by the pulmonary/critical care medicine physician.
Next Document:  PHOX2B mutation-confirmed congenital central hypoventilation syndrome in a chinese family: presentat...